NE-58025: A bisphosphonate with a low hydroxyapatite binding affinity.
作者信息
Pazianas Michael
机构信息
Institute of Musculoskeletal Sciences Oxford University Oxford UK.
出版信息
JBMR Plus. 2021 May 7;5(8):e10502. doi: 10.1002/jbm4.10502. eCollection 2021 Aug.
Abstract
摘要
相似文献
1
NE-58025: A bisphosphonate with a low hydroxyapatite binding affinity.NE-58025：一种与羟基磷灰石结合亲和力较低的双膦酸盐。
JBMR Plus. 2021 May 7;5(8):e10502. doi: 10.1002/jbm4.10502. eCollection 2021 Aug.
2
Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters.双膦酸盐在羟基磷灰石上结合的结构要求：双膦酸盐偏酯的核磁共振研究
ACS Med Chem Lett. 2015 Feb 21;6(4):397-401. doi: 10.1021/ml5004603. eCollection 2015 Apr 9.
3
Evaluation of the interaction between hydroxyapatite and bisphosphonate by nonlinear capillary electrochromatography.采用非线性胶束电动毛细管色谱法评价羟磷灰石与双膦酸盐的相互作用。
J Sep Sci. 2017 May;40(9):2030-2036. doi: 10.1002/jssc.201700028. Epub 2017 Mar 27.
4
Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.合成羟基磷灰石在体外抑制双膦酸盐对口腔黏膜的毒性。
Materials (Basel). 2020 May 1;13(9):2086. doi: 10.3390/ma13092086.
5
Normal osteoconduction and repair in and around submerged highly bisphosphonate-complexed hydroxyapatite implants in rat tibiae.大鼠胫骨中浸没的高度双膦酸盐复合羟基磷灰石植入物及其周围的正常骨传导和修复。
J Periodontol. 2000 Feb;71(2):272-8. doi: 10.1902/jop.2000.71.2.272.
6
Alveolar bone response to submerged bisphosphonate-complexed hydroxyapatite implants.牙槽骨对浸没式双膦酸盐复合羟基磷灰石植入物的反应。
J Periodontol. 2000 Feb;71(2):279-86. doi: 10.1902/jop.2000.71.2.279.
7
Bifunctional bisphosphonate derivatives and platinum complexes with high affinity for bone hydroxyapatite.
Bioorg Med Chem Lett. 2017 Feb 15;27(4):1070-1075. doi: 10.1016/j.bmcl.2016.12.050. Epub 2016 Dec 23.
8
Reply to: A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation.回复：一种低羟基磷灰石结合亲和力的双膦酸盐可预防去卵巢小鼠的骨质流失，并在停止治疗后迅速逆转。
JBMR Plus. 2021 May 6;5(7):e10492. doi: 10.1002/jbm4.10492. eCollection 2021 Jul.
9
Bone-specific drug delivery systems: approaches via chemical modification of bone-seeking agents.骨特异性药物递送系统：通过对趋骨剂进行化学修饰的方法。
Clin Pharmacokinet. 2003;42(15):1319-30. doi: 10.2165/00003088-200342150-00002.
10
A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.一种基于DOTA的双膦酸盐，带有白蛋白结合部分，用于延迟身体清除以实现骨靶向。
Nucl Med Biol. 2016 Nov;43(11):670-678. doi: 10.1016/j.nucmedbio.2016.07.009. Epub 2016 Aug 1.
本文引用的文献
1
A Bisphosphonate With a Low Hydroxyapatite Binding Affinity Prevents Bone Loss in Mice After Ovariectomy and Reverses Rapidly With Treatment Cessation.一种低羟基磷灰石结合亲和力的双膦酸盐可预防去卵巢小鼠的骨质流失，并在停止治疗后迅速逆转。
JBMR Plus. 2021 Mar 3;5(4):e10476. doi: 10.1002/jbm4.10476. eCollection 2021 Apr.
2
Osteonecrosis of the jaw and the role of macrophages.颌骨骨坏死与巨噬细胞的作用。
J Natl Cancer Inst. 2011 Feb 2;103(3):232-40. doi: 10.1093/jnci/djq516. Epub 2010 Dec 28.
3
Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.荧光利塞膦酸盐类似物揭示了破骨细胞吸收骨髓单核细胞和破骨细胞内定位。
J Bone Miner Res. 2010 Mar;25(3):606-16. doi: 10.1359/jbmr.091009.
Zotero 插件